OBJECTIVE: 1) To utilize custom-made micro fluidic chambers to maintain pieces of head and neck tumor in a viable state. 2) To quantify the effects of chemotherapy agents on these tumor biopsies, with the aim of developing a personalized chemotherapy model. METHOD: Fresh pieces (5-10mg) of primary HNSCC or metastatic lymph node were placed in micro fluidic devices and subjected to continuous media perfusion under laminar flow conditions for up to four days. The effluent was evaluated for the concentration of lactate dehydrogenase (LDH); a marker of cell death. Tumor viability was assessed using the cell proliferation reagent WST-1 (both commercial assays, Roche Diagnostics). Architectural changes in the tissue following perfusion were studied by HϩE stained cryostat sections. Following optimization of the approach (nϭ20), tissue was continuously subjected to a concentration of cisplatin and 5-FU equivalent to plasma doses, alone and in combination. RESULTS: LDH reproducibly showed a rapid decrease over the first 12 hours of incubation to minimal detectable levels. Conversely, WST-1 levels increased over four days. The addition of cell lysis buffer at any point resulted in an increase in cell death and reduction in cell proliferation. Preliminary results (nϭ4) for the addition of chemotherapy agents showed cell death when 5-FU or cisplatin were added, with a synergistic effect when given in combination. CONCLUSION: This study demonstrates a robust and reproducible system for the maintenance and interrogation of tumor biopsies. The innovative model provides a new platform for testing individual patient responses to chemotherapy, paving the way for a personalized treatment regimen.
MicroRNAs Expression Profile in Head and Neck Cancer
Valentina Manciocco, PhD (presenter); Federica Ganci; Giulia Fontemaggi; Giovanni Blandino; Giuseppe Spriano OBJECTIVE: Be able to characterize miRNAs signatures with prognostic, predictive, or diagnostic power in HNSCC and at identifying possible correlations with TP53 status. METHOD: Patients with histologically proven HNSCC who underwent surgical treatment without any previous chemo/ radio-therapeutic treatment were included in the study. Three biopsies, from the tumor itself, peri-tumoral tissue, and normal tissue, were obtained for each patient and submitted to RNA and genomic DNA extraction. RESULTS: TP53 status was assessed in 55 patients, by direct sequencing of exons 5 to 8, and 23 out of these 55 showed TP53 mutations. TP53 status was also evaluated in the peritumoral and normal counterparts and a wild-type TP53 sequence was found in all cases. Additionally, cDNA cloning and subsequent sequencing from samples carrying double and triple TP53 mutations showed the existence of different allelic populations, suggesting that these tumors are composed by TP53-heterogeneous cell types. MicroRNAs expression profiling was performed on 55 patients using the Agilent platform. Nineteen miRNAs are differentially regulated in the HNSCC samples when compared with their normal tissue counterparts, while 18 miRNAs are significantly altered in their expression when compared with their peri-tumoral tissue counterparts. CONCLUSION: The data obtained by TP53 cloning suggest the presence of different clonal populations in the tumor. Microarray analysis indicates that microRNAs are strongly modulated between HNSCC tumor and non-tumor samples. Ongoing analyses are integrating microRNAs expression data with clinical information in order to evaluate the predictive/prognostic power of the modulated microRNAs.
Minimally Invasive Balloon Sialodochoplasty & Sialolithotomy
Jonathan Boyd, MD (presenter); Sepehr Oliaei, MD; Marc Rubinstein, MD; Jason Kim, MD OBJECTIVE: At the conclusion of the presentation of this poster, the audience will be able to understand the minimallyinvasive approach for the treatment of recurrent sialolithiasis and use it in select cases. METHOD: Retrospective review of one case of recurrent parotitis with documented presence of a salivary duct calculus. The study was conducted at a University-affiliated institution.
A 46 year old male patient, presented to the emergency room with acute parotitis of several days duration. The patient reported a history of multiple similar episodes, treated with conservative measures (local heat, aggressive hydration sialogogues, and antibiotics). A contrast enhanced computed tomography scan revealed a 5 mm calculus in the parotid duct, with proximal dilatation, significant gland edema and inflammation, with likely phlegmon. The patient was admitted and treated with IV antibiotics. The patient was taken to the OR after failure to improve with conservative measures and concern for abscess. RESULTS: The duct was explored with a lacrimal probe and a moderate amount of pus was expressed from the gland. A 4 Fr Fogarty catheter was then introduced into the duct and advanced past the calculus. The catheter was slowly inflated and withdrawn and the calculus was successfully retrieved
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